|
Volumn 73, Issue 1, 2005, Pages 33-35
|
Some considerations on the origin of type 1 reactions in leprosy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
BACTERIAL ANTIGEN;
CHAULMOOGRA OIL;
CORTICOSTEROID;
LEPROSTATIC AGENT;
OIL;
UNCLASSIFIED DRUG;
ANAMNESIS;
BACILLUS;
BIOPSY;
CLINICAL FEATURE;
CONVALESCENCE;
DIABETES MELLITUS;
DIAGNOSTIC PROCEDURE;
DISABILITY;
DISEASE CLASSIFICATION;
DRUG MECHANISM;
ERYTHEMA;
EXPOSURE;
FACE;
FOOT PAD;
HOST RESISTANCE;
HUMAN;
HYPERSENSITIVITY REACTION;
IMMUNITY;
IMMUNOLOGY;
INCIDENCE;
INOCULATION;
LEPROSY;
LETTER;
LIMB;
METABOLISM;
MYCOBACTERIUM LEPRAE;
NEUROPATHY;
NONHUMAN;
RISK FACTOR;
SENSATION;
STATISTICAL ANALYSIS;
TREATMENT OUTCOME;
TRUNK;
TUBERCULOID LEPROSY;
WORLD HEALTH ORGANIZATION;
ADRENAL CORTEX HORMONES;
DRUG THERAPY, COMBINATION;
HUMANS;
HYPERSENSITIVITY, IMMEDIATE;
LEPROSY;
MYCOBACTERIUM LEPRAE;
WORLD HEALTH ORGANIZATION;
|
EID: 27644574375
PISSN: 0148916X
EISSN: 0148916X
Source Type: Journal
DOI: 10.1489/1544-581X(2005)73[33:SCOTOO]2.0.CO;2 Document Type: Letter |
Times cited : (7)
|
References (0)
|